These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 21512957)
21. Clinical impairment measures and reading performance in a large age-related macular degeneration group. Cacho I; Dickinson CM; Smith HJ; Harper RA Optom Vis Sci; 2010 May; 87(5):344-9. PubMed ID: 20386356 [TBL] [Abstract][Full Text] [Related]
23. Antisaccade performance in patients with multiple sclerosis. Fielding J; Kilpatrick T; Millist L; White O Cortex; 2009; 45(7):900-3. PubMed ID: 19327763 [TBL] [Abstract][Full Text] [Related]
24. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study. Bergendal G; Fredrikson S; Almkvist O Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938 [TBL] [Abstract][Full Text] [Related]
25. A comprehensive assessment of visual impairment in a population of older Americans. The SEE Study. Salisbury Eye Evaluation Project. Rubin GS; West SK; Muñoz B; Bandeen-Roche K; Zeger S; Schein O; Fried LP Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):557-68. PubMed ID: 9071208 [TBL] [Abstract][Full Text] [Related]
26. Neuropsychological impairment-associated visual field deficits in HIV infection. HNRC Group. HIV Neurobehavioral Research Center. Plummer DJ; Marcotte TD; Sample PA; Wolfson T; Heaton RK; Grant I; Freeman WR Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):435-42. PubMed ID: 9950603 [TBL] [Abstract][Full Text] [Related]
27. Simulated cataract and low contrast stimuli impair cognitive performance in older adults: implications for neuropsychological assessment and everyday function. See AY; Anstey KJ; Wood JM Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2011 Jan; 18(1):1-21. PubMed ID: 20799104 [TBL] [Abstract][Full Text] [Related]
28. Utility of the National Eye Institute VFQ-25 questionnaire in a heterogeneous group of multiple sclerosis patients. Noble J; Forooghian F; Sproule M; Westall C; O'Connor P Am J Ophthalmol; 2006 Sep; 142(3):464-8. PubMed ID: 16935592 [TBL] [Abstract][Full Text] [Related]
29. Value of Pelli-Robson contrast sensitivity chart for evaluation of visual system in multiple sclerosis patients. Wender M Neurol Neurochir Pol; 2007; 41(2):141-3. PubMed ID: 17530576 [TBL] [Abstract][Full Text] [Related]
30. The detection of hidden visual loss in optic neuropathy: VISTECH test at variable illuminations. Leys MJ; Candaele CM; Uvijls AG; Heintz BF; De Rouck AF; Odom JV Bull Soc Belge Ophtalmol; 1990; 236():57-65. PubMed ID: 2093407 [TBL] [Abstract][Full Text] [Related]
31. Persistent visual impairment in multiple sclerosis: prevalence, mechanisms and resulting disability. Jasse L; Vukusic S; Durand-Dubief F; Vartin C; Piras C; Bernard M; Pélisson D; Confavreux C; Vighetto A; Tilikete C Mult Scler; 2013 Oct; 19(12):1618-26. PubMed ID: 23462348 [TBL] [Abstract][Full Text] [Related]
32. Information-processing speed is the primary deficit underlying the poor performance of multiple sclerosis patients in the Paced Auditory Serial Addition Test (PASAT). Forn C; Belenguer A; Parcet-Ibars MA; Avila C J Clin Exp Neuropsychol; 2008 Oct; 30(7):789-96. PubMed ID: 18608672 [TBL] [Abstract][Full Text] [Related]
33. Metamemory and tested cognitive functioning in multiple sclerosis. Randolph JJ; Arnett PA; Higginson CI Clin Neuropsychol; 2001 Aug; 15(3):357-68. PubMed ID: 11778774 [TBL] [Abstract][Full Text] [Related]
34. Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Balcer LJ; Galetta SL; Calabresi PA; Confavreux C; Giovannoni G; Havrdova E; Hutchinson M; Kappos L; Lublin FD; Miller DH; O'Connor PW; Phillips JT; Polman CH; Radue EW; Rudick RA; Stuart WH; Wajgt A; Weinstock-Guttman B; Wynn DR; Lynn F; Panzara MA Neurology; 2007 Apr; 68(16):1299-304. PubMed ID: 17438220 [TBL] [Abstract][Full Text] [Related]
35. Effect of visual impairment on neuropsychological test performance. Kempen JH; Krichevsky M; Feldman ST J Clin Exp Neuropsychol; 1994 Apr; 16(2):223-31. PubMed ID: 8021309 [TBL] [Abstract][Full Text] [Related]
37. Response variability is associated with self-reported cognitive fatigue in multiple sclerosis. Bruce JM; Bruce AS; Arnett PA Neuropsychology; 2010 Jan; 24(1):77-83. PubMed ID: 20063948 [TBL] [Abstract][Full Text] [Related]
38. Dynamic measures of visual function and their relationship to self-report of visual functioning. Freeman EE; Muñoz B; Turano KA; West SK Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4762-6. PubMed ID: 17065485 [TBL] [Abstract][Full Text] [Related]
39. Cognitive functioning in children with multiple sclerosis. Montiel-Nava C; Peña JA; González-Pernía S; Mora-La Cruz E Mult Scler; 2009 Feb; 15(2):266-8. PubMed ID: 18922833 [TBL] [Abstract][Full Text] [Related]
40. A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters. Denney DR; Lynch SG; Parmenter BA J Neurol Sci; 2008 Apr; 267(1-2):129-36. PubMed ID: 17976653 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]